FRESUBIN ENERGY DRINK NEUTRAL

Základní informace

  • Název přípravku:
  • FRESUBIN ENERGY DRINK NEUTRAL Perorální roztok
  • Léková forma:
  • Perorální roztok
  • Podání:
  • Perorální podání
  • Jednotky v balení:
  • 4X200ML Lahev
  • Použij pro:
  • Lidé
  • Léčitelství typu:
  • alopatický drog

Dokumenty

Lokalizace

  • K dispozici v:
  • FRESUBIN ENERGY DRINK NEUTRAL Perorální roztok
    Česká republika
  • Jazyk:
  • čeština

Terapeutická informace

  • Terapeutické oblasti:
  • POTRAVINY PRO ZVLÁŠTNÍ LÉKAŘSKÉ ÚČELY (PZLÚ)
  • Přehled produktů:
  • FRESUBIN ENERGY DRINK NEUTRAL

Další informace

Stav

  • Zdroj:
  • SUKL - Státní ústav pro kontrolu léčiv
  • EAN kód:
  • 4051895007618
  • Poslední aktualizace:
  • 22-06-2017

Příbalovou informaci pro pacienta

CZ
Fresubin energy DRINK 4 x 200 ml
150 kcal/100 ml 300 kcal/1260 kJ (v 200 ml) Osmolarita 355 mosmol/l B 15 kJ % T 35 kJ % S 50 kJ % Vláknina 0 kJ %
Dietní potravina pro zvláštní lékařské účely. Příchuť: NEUTRAL
Nutričně kompletní výživa s vysokou energetickou hodnotou 1,5 kcal/ml určená k popíjení bez vlákniny. Klinicky bez laktózy a bez lepku. Výživa určená k dietnímu režimu pro pacienty s nebo bez rizika podvýživy. Nejlépe chutná vychlazený. Baleno v ochranné atmosféře.
Důležité upozornění: Užívat na základě doporučení lékaře nebo osoby kvalifikované v oblasti výživy lidí, farmacie nebo péče o matku a dítě. Určeno k doplňkové výživě (≥ 2-3 lahvičky/den) nebo k celkové výživě (≥ 5-7 lahviček/den). Nepodávat dětem mladším 1 rok. Zajistěte dostatečný příjem tekutin. Pijte pomalu! Maximální dávkování nesmí překročit 7 lahviček (80 g bílkovin) za den. Není vhodné jako jediný zdroj výživy pro děti mladší 5 let. Uchovávání: Uchovávejte při pokojové teplotě. Otevřené lahvičky mohou být uchovávány v chladničce po dobu až 24 hodin. Spotřebujte do data uvedeného na obalu. Složení přípravku: voda, maltodextrin, mléčná bílkovina, rostlinné oleje, sacharóza, citronan draselný, citronan sodný, emulgátory (sójový lecithin, E471), chlorid sodný, chlorid draselný, vit. C, regulátory kyselosti (E 330, E 530), cholin-chlorid, difosforečnan železitý, síran zinečnatý, niacin, vit. E, kyselina pantothenová, chlorid manganatý, síran měďnatý, vit. B6, vit. B2, fluorid sodný, vit. B1, betakaroten, vit. A, kyselina listová, chlorid chromitý, jodid draselný, molybdenan sodný, seleničitan sodný, vit K1, biotin, vit. D3, vit. B12. Průměrný obsah ve 100 ml roztoku: energetická hodnota 630 kJ (150 kcal); bílkoviny 5,6 g; sacharidy 18,8 g (z toho cukry 3,9 g, z toho laktóza ≤ 0,27g); tuky 5,8 g (z toho nasycené mastné kys. 0,4 g, mononenasycené mastné kys. 3,8 g, polynenasycené mastné kys. 1,6 g); vláknina 0 g; voda 78 ml. Vitaminy a ostatní živiny ve 100 ml roztoku: vit. A 120 µg, betakaroten 300 µg, vit. D3 2 µg, vit. E 3 mg, vit. K1 16,7 µg, vit. B1 0,23 mg, vit. B2 0,32 mg, niacin 3 mg, vit. B6 0,33 mg, vit. B12 0,6 µg, kys. pantothenová 1,2 mg, biotin 7,5 µg, kys. listová 50 µg, vit. C 15 mg, cholin 26,7 mg Minerály a stopové prvky ve 100 ml roztoku: Na 80 mg, K 135 mg, Cl 100 mg, Ca 135 mg, Mg 21 mg, P 80 mg, Fe 2 mg, Zn 1,5 mg, Cu 300 µg, Mn 0,4 mg, I 30 µg, F 0,2 mg, Cr 10 µg, Mo 15 µg, Se 10 µg
Není prodejné samostatně!
Výrobce: Fresenius Kabi Deutschland GmbH, D-61346 Bad Homburg, Německo http://www.fresenius-kabi.com
Distributor: Fresenius Kabi s.r.o., Praha, Česká republika

Ver 01



27-9-2018

Health Canada reminds Canadians not to mix caffeinated drinks with alcohol

Health Canada reminds Canadians not to mix caffeinated drinks with alcohol

September 27, 2018 Ottawa Health Canada

Health Canada

29-8-2018

Scientific Opinion on the state of the art of Toxicokinetic/Toxicodynamic (TKTD) effect models for regulatory risk assessment of pesticides for aquatic organisms

Scientific Opinion on the state of the art of Toxicokinetic/Toxicodynamic (TKTD) effect models for regulatory risk assessment of pesticides for aquatic organisms

Published on: Thu, 23 Aug 2018 00:00:00 +0200 Following a request from EFSA, the Panel on Plant Protection Products and their Residues (PPR) developed an opinion on the state of the art of Toxicokinetic/Toxicodynamic (TKTD) models and their use in prospective environmental risk assessment (ERA) for pesticides and aquatic organisms. TKTD models are species‐ and compound‐specific and can be used to predict (sub)lethal effects of pesticides under untested (time‐variable) exposure conditions. Three differen...

Europe - EFSA - European Food Safety Authority Publications

22-8-2018

UPDATED: Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine and Valsartan Tablets

UPDATED: Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine and Valsartan Tablets

Torrent Pharmaceuticals Limited is voluntarily recalling ALL LOTS within expiry of Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine and Valsartan tablets to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Zhejiang Huahai Pharmaceuticals. The impurity detected in the API is N-nitrosodimethylamine (NDMA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industr...

FDA - U.S. Food and Drug Administration

18-8-2018

Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Valsartan / Amlodipine / HCTZ Tablets

Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Valsartan / Amlodipine / HCTZ Tablets

Torrent Pharmaceuticals Limited is voluntarily recalling 14 lots of Valsartan/Amlodipine/HCTZ tablets to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Zhejiang Huahai Pharmaceuticals. The impurity detected in the API is N-nitrosodimethylamine (NDMA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probabl...

FDA - U.S. Food and Drug Administration

17-7-2018

Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of Valsartan and Valsartan Hydrochlorothiazide Tablets

Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of Valsartan and Valsartan Hydrochlorothiazide Tablets

Teva Pharmaceuticals USA today confirmed a voluntary recall to the consumer / user level of 29 lots of single and 51 lots of combination valsartan medicines distributed under the Actavis label in the U.S. due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Zhejiang Huahai Pharmaceutical. The impurity detected in the API is N- nitrosodimethylamine (NDMA), which is a substance that occurs naturally in certain foods, drinking wat...

FDA - U.S. Food and Drug Administration

6-7-2018

Blokhuis: maatregelen nodig tegen probleemgebruik energiedrankjes

Blokhuis: maatregelen nodig tegen probleemgebruik energiedrankjes

Een relatief kleine groep jongeren tussen de 13 en 18 jaar drinkt te veel energiedrank en loopt daarmee risico op gezondheidsklachten. Dat blijkt uit onderzoek dat het RIVM uitvoerde in opdracht van staatssecretaris Paul Blokhuis (VWS) naar aanleiding van signalen van kinderartsen eerder dit jaar. Over het algemeen is de consumptie van energiedrankjes onder jongeren de afgelopen jaren afgenomen. Vier op de vijf jongeren drinkt het nooit of minder dan wekelijks.

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

19-6-2018

Meltz – Instant Energy For Males tablets

Meltz – Instant Energy For Males tablets

Meltz Instant Energy For Males tablets pose a serious risk to your health and should not be taken.

Therapeutic Goods Administration - Australia

6-6-2018

FDA Deputy Commissioner for Policy, Planning, Legislation, and Analysis Anna Abram, remarks prepared for testimony before a subcommittee of the U.S. House Committee on Energy and Commerce on the Pandemic and All-Hazards Preparedness Act

FDA Deputy Commissioner for Policy, Planning, Legislation, and Analysis Anna Abram, remarks prepared for testimony before a subcommittee of the U.S. House Committee on Energy and Commerce on the Pandemic and All-Hazards Preparedness Act

FDA’s Anna Abram’s testimony for U.S. House Committee on Energy and Commerce Subcommittee on Health on the Pandemic and All-Hazards Preparedness Act

FDA - U.S. Food and Drug Administration

29-5-2018

Pious Lion Voluntary Recall Due to Possible Health Risk

Pious Lion Voluntary Recall Due to Possible Health Risk

Pious Lion located in Asheville, NC is voluntarily recalling two of their Kratom products: Pious Lion Pure Premium Potent Limited Release Pink Bali, 1 oz and Pious Lion Pure Premium Potent White Maeng DA, Bright Uplifting Energy, 4 oz due to the presence of Salmonella . Salmonella is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhe...

FDA - U.S. Food and Drug Administration

15-5-2018

Public Notification: Best Candy contains hidden drug ingredient

Public Notification: Best Candy contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use Best Candy, a product promoted as an energy booster on various websites and possibly in some retail stores. This product was identified during an examination of imported goods.

FDA - U.S. Food and Drug Administration

1-5-2018

Do You Vape? See These Tips on How to Keep E-Liquids Away from Children

Do You Vape? See These Tips on How to Keep E-Liquids Away from Children

Accidentally touching or drinking e-liquids can be dangerous and even deadly for young children. So it’s important to handle and store these products carefully, to teach children to stay away from these products, and to be prepared for emergencies. Consider these tips.

FDA - U.S. Food and Drug Administration

22-2-2012

Decision on general conditional reimbursement for alendronate-containing medicines

Decision on general conditional reimbursement for alendronate-containing medicines

In cooperation with the Reimbursement Committee, we have decided to grant alendronate-containing medicines general conditional reimbursement from 5 March 2012. Reimbursement is conditional as it is reserved for patients with low-energy hip fractures. For any other patients who are treated with alendronate, the doctor must apply for single reimbursement, and the guiding criteria for single reimbursement remain unchanged for these patients. Alendronate is used for the treatment of osteoporosis (brittle bon...

Danish Medicines Agency

30-7-2018

#FDA Warns Against Use of Energy-Based Devices to Perform Vaginal “Rejuvenation” or Vaginal Cosmetic Procedures  http://go.usa.gov/xUdgB  #MedicalDevice

#FDA Warns Against Use of Energy-Based Devices to Perform Vaginal “Rejuvenation” or Vaginal Cosmetic Procedures http://go.usa.gov/xUdgB  #MedicalDevice

#FDA Warns Against Use of Energy-Based Devices to Perform Vaginal “Rejuvenation” or Vaginal Cosmetic Procedures http://go.usa.gov/xUdgB  #MedicalDevice

FDA - U.S. Food and Drug Administration